CMPS 241220 7.50P (CMPS241220P7500) Stock Options, News & Quotes

US OptionsDetailed Quotes

CMPS241220P7500

Watchlist

3.00
+1.04+53.06%

15min DelayClose Nov 21 16:00 ET

3.00High3.00Low

Intraday

5D
Daily

News

European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday
MT Newswires11:20 ET
Despegar.com, Zai Lab, Bloom Energy And Other Big Stocks Moving Higher On Friday
BenzingaNov 15 10:12 ET
Express News | U.S.-Listed Shares of ATAI Life Sciences up 9.1%
ReutersNov 15 09:34 ET
Express News | GH Research Shares up 4.1%
ReutersNov 15 09:33 ET
Express News | Compass Pathways Shares up 11.9%
ReutersNov 15 09:33 ET
Express News | Shares of Psychedelic Drug Developers Rise After Rfk Jr Picked for Top US Health Agency Role
ReutersNov 15 09:33 ET

Comments

IDKWTFIMDOING

Jul 22 04:21

$COMPASS Pathways (CMPS.US)$
https://www.fda.gov/news-events/press-announcements/fda-issues-first-draft-guidance-clinical-trials-psychedelic-drugs

Jaguar8

May 8 05:31

$COMPASS Pathways (CMPS.US)$
NEWS
Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder

Jaguar8

May 2 06:00

$COMPASS Pathways (CMPS.US)$
NEWS
Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment

Moomoo AI

Jan 3 10:34

Cody Shandraw of Ambria Capital suggests FDA approval for MDMA legalization could be imminent, asserting that MDMA therapy might follow a similar trajectory to JNJ's Spravato treatment for depression. He is thrilled about the potential coverage of the therapy by the U.S. Department of Veterans Affairs for military personnel.

Why One Backer of MDMA Therapy Sees 'Exponential' Growth Following FDA Approval This Year

FiReBiTriXiE

Oct 21, 2023 22:52

Watchlisting👀

$COMPASS Pathways (CMPS.US)$